
Biological age diagnostics, NMN, NAD+ infusions, genomic testing, TCM-integrated longevity protocols: China is developing a complex and rapidly evolving ecosystem around anti-aging and healthspan optimization. Here are the most serious addresses, the distinctive landscape, and how to navigate it.
Alongside its ancient tradition of longevity medicine rooted in Traditional Chinese Medicine and its world-class academic research institutions, China is witnessing the emergence of a third ecosystem: clinical structures and premium private centers dedicated to biological age diagnostics and longevity optimization, concentrated in Beijing, Shanghai, Shenzhen, and Xi’an. The sector is dynamic, commercially highly active, but subject to a regulatory framework that draws a clear line between diagnostics and the more experimental therapies being sold around them. Understanding that line is the essential starting point for any serious longevity traveler or resident.
Ancient roots, modern genomics: a singular ecosystem
China’s relationship with longevity is ancient. The Daoist quest for long life, the emphasis on preventive medicine in TCM, and the cultural reverence for centenarians form a backdrop unlike any other country. What is new is the convergence of this tradition with world-class genomic sequencing infrastructure ; China hosts some of the largest DNA sequencing facilities globally ; and a consumer market that has embraced NMN and NAD+ with extraordinary enthusiasm.
One essential caveat frames everything that follows. Chinese health authorities have drawn a hard regulatory line between research and treatment. Stem cell therapies and most experimental regenerative treatments cannot legally be sold as anti-aging protocols, even as more than a hundred institutions have been licensed to conduct stem cell clinical studies. Public longevity clinic structures focus on diagnostics and prevention within established frameworks. The gray market around NMN, NAD+ infusions, and related supplements is large, fast-growing, and loosely regulated. This article focuses on the credible, diagnostically anchored options ; the ones worth visiting.
Diagnostics: biological age in the Chinese public and private hospital system
Before any serious protocol comes measurement. The most credible diagnostic longevity work in China is concentrated in the academic medical sector, where the infrastructure and clinical oversight are most robust.
Peking Union Medical College Hospital (PUMCH) — Longevity Clinic (Beijing)
One of China’s most prestigious academic medical institutions, PUMCH has opened a dedicated longevity clinic within its preventive medicine framework. Its approach is diagnostic and prevention-oriented: biological age assessment through blood biomarkers, hormone panels, body composition scanning, and cardiovascular risk profiling, followed by personalized diet and exercise planning rather than experimental interventions.

This is the most academically credible longevity diagnostic address in Beijing. The clinical standards are those of a leading public hospital ; rigorous, conservative, and grounded in evidence. It is not a biohacking center, but it is where the evidence base for longevity diagnostics in China is most reliably applied. International patients can access services through the hospital’s VIP or international department.
Ruijin Hospital — Longevity Clinic (Shanghai)
One of the first public institutions in China to formalize a longevity clinic structure, Ruijin Hospital’s program similarly focuses on diagnostics and prevention: metabolic markers, inflammatory profiles, hormonal panels, and body composition, interpreted through the lens of biological rather than chronological age. The clinical team designs personalized lifestyle and metabolic optimization strategies. Ruijin’s reputation in endocrinology and internal medicine makes it a credible anchor for longevity diagnostics in Shanghai. As with PUMCH in Beijing, the positioning is clinical and prevention-oriented rather than biohacking in the commercial sense.
Xi’an International Medical Center — Genetic and Longevity Diagnostics
For international patients seeking comprehensive genetic and longevity screening at significantly lower cost than Western markets, Xi’an International Medical Center (through platforms such as MedTourChina) has emerged as a notable option. A comprehensive assessment covering cancer risk genes, cardiovascular genetic panels, pharmacogenomics, and aging biomarkers is available at a fraction of the cost charged in Singapore or the United States.

The center offers access to China’s advanced genomics sequencing infrastructure at clinical quality. This is particularly relevant for health-conscious international travelers or residents seeking a deep genetic workup as a longevity baseline. English-language coordination is available through specialist medical tourism platforms.
Jiahui International Hospital (Shanghai)
A premium private hospital with an international standard of service and English-speaking clinical teams. It offers targeted genetic testing panels ; cancer gene screening, pharmacogenomic testing, cardiovascular genetic profiling ; separately or as add-ons to standard executive health check packages. A genetic counselor reviews family history and guides test selection. For expatriates in Shanghai seeking genomic-level longevity diagnostics in a familiar clinical environment, Jiahui represents a credible private-sector entry point.

NMN, NAD+ and the consumer boom: where to exercise extra discernment
Beyond the academic hospital sector, China’s anti-aging consumer market is one of the most active in the world ; and also one of the most heterogeneous.
NAD+ infusion clinics in luxury gyms and private centers (Beijing, Shanghai, Shenzhen)
NAD+ “recharge drips” have proliferated across major Chinese cities, offered in luxury gym facilities, private wellness clinics, and medical spas, often advertised under terms like “cellular detox” or “energy renewal.” Sessions are priced at up to 8,000 yuan or more, often through platforms tied to luxury fitness brands. The appeal is real ; NAD+ has a genuine scientific foundation ; but the clinical supervision, dosing protocols, and quality of products administered vary enormously across this unregulated segment. A session at a credible private hospital-affiliated clinic is a fundamentally different proposition from one at a gym-adjacent wellness center. Always verify the medical supervision structure before committing.
NMN supplements (nationwide)
China’s NMN supplement market reached an estimated 8.5 billion yuan in 2024 and is expanding rapidly. The products range from credible, well-manufactured options to gray-market imports of uncertain quality. Discussion communities on platforms like Xiaohongshu are active but conflicted ; self-experimentation reports range from genuine reported benefits to adverse reactions. As with any longevity supplement, the principle of measure first applies: knowing your baseline NAD+ status and metabolic profile before investing in an NMN regimen is far more sensible than self-prescribing based on social media.
The Sogevity framework: 4 criteria to sort through
In a market this dynamic and commercially active, sorting capacity matters more than lists.
Diagnosis first
The most credible Chinese longevity addresses : PUMCH, Ruijin, Jiahui, Xi’an IMC ; all begin with a rigorous biomarker workup before any protocol is proposed. Be very cautious of centers that offer NAD+ infusions or supplement protocols without a prior diagnostic baseline.
Medical supervision next
The critical question is whether a physician trained in longevity or functional medicine is overseeing the protocol ; or whether the clinical veneer is thin. In the public hospital sector, this standard is generally met. In the private wellness and gym-adjacent sector, it must be verified independently. The presence of genetic counselors, endocrinologists, or internal medicine specialists is a strong quality signal.

The level of evidence of the protocols
Diagnostics, metabolic profiling, hormone assessment, and IV nutrient therapy under medical supervision fall under established frameworks. Stem cell therapies as anti-aging treatments are illegal to sell commercially in China. NMN and high-dose NAD+ supplementation have genuine scientific interest but still-limited clinical trial data in humans. Approach aggressive commercial claims in this space with proportional skepticism.
Transparency last
Hospital licensing, laboratory accreditation, clinical team credentials ; credible structures make these visible. International patients should use accredited hospitals or specialist medical tourism platforms that verify clinical standards independently. Avoid centers that cannot clearly articulate who is medically responsible for a protocol.
Key takeaways
China offers a genuinely remarkable longevity diagnostics opportunity ; particularly in genomic testing, where the combination of world-class sequencing infrastructure and competitive pricing creates access that is hard to match anywhere. The academic public hospital longevity clinics in Beijing and Shanghai represent credible, evidence-grounded diagnostic anchors. But China is also the world’s most commercially exuberant anti-aging market, with an enormous gray zone between serious clinical practice and supplement-fueled consumer enthusiasm.
The rule for China is the same as everywhere: start with diagnostics, verify clinical supervision, and maintain healthy skepticism toward any intervention that cannot be traced to a clear regulatory and medical framework. The best entry point is a comprehensive genetic and biomarker workup at a credible institution ; not a NAD+ drip in a luxury gym.
What about you: would you start by mapping your biological age through genomics, or by testing an optimization protocol directly?
Disclaimer: this article is for informational purposes and does not constitute medical advice. Many of the protocols mentioned have variable or experimental levels of evidence. Consult a healthcare professional before starting any program. Travelers should verify current regulatory frameworks before seeking specific treatments in China.